PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195 | -42.3% | 11,720 | -4.1% | 0.02% | -41.4% |
| Q2 2023 | $338 | +20.3% | 12,220 | 0.0% | 0.03% | +11.5% |
| Q1 2023 | $281 | -39.0% | 12,220 | -71.1% | 0.03% | -40.9% |
| Q4 2022 | $461 | -99.9% | 42,220 | 0.0% | 0.04% | +22.2% |
| Q3 2022 | $356,000 | +6.6% | 42,220 | 0.0% | 0.04% | +12.5% |
| Q2 2022 | $334,000 | -36.5% | 42,220 | +90.0% | 0.03% | -23.8% |
| Q1 2022 | $526,000 | -30.8% | 22,220 | 0.0% | 0.04% | -26.3% |
| Q4 2021 | $760,000 | +92.9% | 22,220 | 0.0% | 0.06% | +72.7% |
| Q3 2021 | $394,000 | -56.7% | 22,220 | +9.7% | 0.03% | -57.1% |
| Q2 2021 | $909,000 | +57.8% | 20,250 | -9.0% | 0.08% | +45.3% |
| Q1 2021 | $576,000 | +28.3% | 22,250 | 0.0% | 0.05% | +20.5% |
| Q4 2020 | $449,000 | +3.2% | 22,250 | 0.0% | 0.04% | -6.4% |
| Q3 2020 | $435,000 | +5.8% | 22,250 | -4.5% | 0.05% | -4.1% |
| Q2 2020 | $411,000 | +147.6% | 23,300 | -0.9% | 0.05% | +104.2% |
| Q1 2020 | $166,000 | 0.0% | 23,500 | 0.0% | 0.02% | +20.0% |
| Q4 2019 | $166,000 | -41.1% | 23,500 | 0.0% | 0.02% | -44.4% |
| Q3 2019 | $282,000 | -1.1% | 23,500 | 0.0% | 0.04% | -2.7% |
| Q2 2019 | $285,000 | -3.4% | 23,500 | 0.0% | 0.04% | -9.8% |
| Q1 2019 | $295,000 | +86.7% | 23,500 | 0.0% | 0.04% | +64.0% |
| Q4 2018 | $158,000 | -43.2% | 23,500 | -13.0% | 0.02% | -34.2% |
| Q3 2018 | $278,000 | +51.9% | 27,000 | -1.1% | 0.04% | +40.7% |
| Q2 2018 | $183,000 | -54.4% | 27,300 | -41.5% | 0.03% | -55.0% |
| Q1 2018 | $401,000 | -58.7% | 46,700 | 0.0% | 0.06% | -58.6% |
| Q4 2017 | $971,000 | +229.2% | 46,700 | +179.6% | 0.14% | +202.1% |
| Q3 2017 | $295,000 | – | 16,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |